Company Active LTD

Company profile

Occuity Ltd

Optical Healthcare Monitoring And Screening | Occuity

Occuity specialises in the design and production of handheld optical healthcare monitoring and screening devices for clinical and personal use.

CRN
12192959
Founded
2019
Age
6

Overview

Legal name
OCCUITY LTD
Region
London
Registered address
27 OLD GLOUCESTER STREET
LONDON
UNITED KINGDOM
WC1N 3AX
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

22 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

07 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzODU4MTg4N2FkaXF6a2N4

Published 07 Oct 2024 11:14

06 Sep
2019

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2020
Funded years
2020, 2022, 2024
Age at first award
0 years

Projects

2024 Collaborative R&D Lead participant

Myopia: Probing the reciprocal relationship between ocular structure and visual function

1 Nov 2024 to 31 Oct 2029

Awarded
£1,644,039
Total cost £1,644,039
2024 Small Business Research Initiative Lead participant

The Aβ+ Reader: A novel hyperspectral fluorescence-lifetime imaging device for detection of dementia biomarkers in the lens of the eye

1 Feb 2024 to 31 Jan 2025

Awarded
£511,054
Total cost £511,054

Dementia is a debilitating syndrome that is associated with an ongoing decline of brain functioning. In the UK alone, "dementia and Alzheimer's disease" is the leading cause of death, accounting for 11.4% of all deaths in 2022, with an annual economic cost of over £34.7 billion. A major barrier for both timely diagnosis and development of effective treatm...

2022 Collaborative R&D Lead participant

Non-contact optical meter for diabetes screening in non-clinical settings

1 Dec 2022 to 29 Feb 2024

Awarded
£343,216
Total cost £490,309

Type 2 diabetes(T2D) is characterised by insulin resistance leading to high blood glucose levels(BG) and affects 4.8mn people in the UK and 422mn globally. Prevalence is rising in most countries; globally 700mn people are predicted to have diabetes, and 374mn pre-diabetes by 2045\. Prediabetes is reversible however, most people aren't diagnosed until they...

2020 Study Lead participant

OccuLook - a non-invasive blood glucose meter for diabetes care

1 Jun 2020 to 31 Aug 2021

Awarded
£144,325
Total cost £206,179

Diabetes is a long-term disease that occurs when the pancreas stops making insulin or when the body cannot effectively use the insulin that is produced. People with diabetes have an increased risk of developing serious health problems including heart disease, blindness, kidney failure and lower limb amputation Diabetes is increasing at an alarming rate th...

Product types

Collaborative R&D Small Business Research Initiative Study